Market Overview

Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK)

4.22 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/22/18BairdMaintainsNeutral4.0
6/26/18BairdMaintainsNeutral7.0
6/25/18JP MorganDowngradesUnderweight
10/07/16JP MorganDowngradesNeutral
8/19/16BTIG ResearchInitiates Coverage onNeutral
8/05/16JP MorganMaintainsOverweight8.0
5/26/16BairdInitiates Coverage onNeutral
10/27/15OppenheimerMaintainsOutperform15.0
8/12/15OppenheimerAssumesOutperform13.0
5/13/15GuggenheimInitiates Coverage onBuy15.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter